Brentuximab Vedotin

Category: Cancer



Brentuximab Vedotin Overview

Brentuximab vedotin (INN, trade name Adcetris) is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL). It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL (a type of T cell non-Hodgkin lymphoma).[1] Contents 1 Approvals and indications 1.1 Approval In Australia 2 Design 3 Clinical trials 4 Serious adverse events 4.1 ...

Read more Brentuximab Vedotin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Brentuximab_vedotin

Recent Brentuximab Vedotin Forums: RSS Feed

Refractory Hodgkin's lymphoma

Information needed Refractory Hodgkin's lymphoma and Brentuximab Vedotin ## From what I could gather, Brentuximab vedotin injection is used in patients with Hodgkin's lymphoma who have otherwise not responded to stem cell transplants (procedure that replaces diseased bone marrow with healthy bone marrow) or at least two treatments of chemotherapy. More information on Brentuximab vedotin injection can be found by visiting the webpage below: nlm.nih.gov/medlineplus/druginfo/meds/a611052.html Refractory Hodgkin's lymphoma is basically a form of cancer pertaining to the white blood cells (lymphocytes); which make up a large part of the lymphatic system. The term Refractory simply means that the lymphoma is resistant to primary treatment options. You can find more specific detail...

Updated

Possible Dosages for this and Related Drugs:

Brentuximab Vedotin
  • Injection: 50mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Brentuximab Vedotin or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA